| Literature DB >> 32782284 |
Emanuele Capra1, Barbara Lazzari1, Marco Russo2, Michal Andrzej Kosior2, Giovanni Della Valle2, Valentina Longobardi2, Alessandra Stella1, Anna Lange Consiglio3,4, Bianca Gasparrini2.
Abstract
Season clearly influences oocyte competence in buffalo (Bubalus bubalis); however, changes in the oocyte molecular status in relation to season are poorly understood. This study characterizes the microRNA (miRNA) and transcriptomic profiles of oocytes (OOs) and corresponding follicular cells (FCs) from buffalo ovaries collected in the breeding (BS) and non-breeding (NBS) seasons. In the BS, cleavage and blastocyst rates are significantly higher compared to NBS. Thirteen miRNAs and two mRNAs showed differential expression (DE) in FCs between BS and NBS. DE-miRNAs target gene analysis uncovered pathways associated with transforming growth factor β (TGFβ) and circadian clock photoperiod. Oocytes cluster in function of season for their miRNA content, showing 13 DE-miRNAs between BS and NBS. Between the two seasons, 22 differentially expressed genes were also observed. Gene Ontology (GO) analysis of miRNA target genes and differentially expressed genes (DEGs) in OOs highlights pathways related to triglyceride and sterol biosynthesis and storage. Co-expression analysis of miRNAs and mRNAs revealed a positive correlation between miR-296-3p and genes related to metabolism and hormone regulation. In conclusion, season significantly affects female fertility in buffalo and impacts on oocyte transcriptomic of genes related to folliculogenesis and acquisition of oocyte competence.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32782284 PMCID: PMC7419291 DOI: 10.1038/s41598-020-70546-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Principal component analysis considering (a) the 467 miRNAs expressed at least in triplicate in the oocytes (OOs), (b) the 635 miRNAs expressed at least in triplicate in the Follicular cells (FCs). Samples 1–5 from non-breeding season (NBS), samples 6–10 from breeding season (BS).
Differentially expressed miRNAs DE-miRNAs (false discovery rate (FDR) < 0.05) between the two seasons (NBS = non breeding season, BS = breeding season) for oocytes (OOs) and follicular cells (FCs).
| OOs (NBS vs BS) | FCs (NBS vs BS) | ||||
|---|---|---|---|---|---|
| miRNAs | logFC | FDR | miRNAs | logFC | FDR |
| bta-miR-143 | − 2.07 | 5.42E−05 | Novel:NC_037567.1_45577 | 2.65 | 1.69E−05 |
| Novel:NC_037550.1_18643 | 1.58 | 7.24E−04 | Novel:NC_037553.1_23674 | 2.09 | 3.78E−05 |
| bta-miR-199a-3p | − 2.10 | 7.24E−04 | Novel:chi-miR-184 | − 4.24 | 1.54E−04 |
| bta-miR-1468 | − 1.83 | 3.69E−03 | bta-miR-2904 | − 2.90 | 2.50E−04 |
| bta-miR-25 | − 0.91 | 1.44E−02 | Novel:NC_037550.1_18643 | − 2.37 | 4.25E−04 |
| bta-miR-1388-5p | − 4.55 | 3.55E−02 | bta-miR-2411-3p | − 2.01 | 1.54E−03 |
| bta-miR-296-3p | − 1.41 | 3.91E−02 | bta-miR-2440 | − 1.86 | 2.98E−03 |
| Novel:NC_037557.1_30140 | − 1.36 | 3.91E−02 | bta-miR-2332 | − 1.47 | 4.48E−03 |
| Novel:NC_037569.1_47305 | − 1.36 | 3.91E−02 | bta-miR-141 | − 3.73 | 4.48E−03 |
| Novel:NC_037564.1_42998 | − 1.36 | 3.91E−02 | bta-miR-2478 | 1.68 | 4.97E−03 |
| bta-miR-331-5p | − 4.19 | 4.12E−02 | bta-miR-34b | − 4.11 | 8.16E−03 |
| bta-miR-199a-5p | − 2.09 | 4.47E−02 | bta-miR-34c | − 4.02 | 8.16E−03 |
| bta-miR-222 | − 1.35 | 4.95E−02 | bta-miR-486 | 0.96 | 3.65E−02 |
Figure 2Box Plot of the most significant (top six sorted by FDR value) differentially expressed miRNAs (DE-miRNAs) in (a) oocyte and (b) follicular cells from animals between breeding season (BS) and non breeding season (NBS).
GO terms identified for the target genes of differentially expressed miRNAs between the two seasons for oocytes (OOs) and Follicular Cells (FCs).
| GOID | Associated genes found | GO term | ||
|---|---|---|---|---|
| 0010866 | [DGAT2, FITM2, NR1H3] | Regulation of triglyceride biosynthetic process | 0.004 | |
| 0060742 | [NOTCH1, SFTPA1, SFTPA2] | Epithelial cell differentiation involved in prostate gland development | 0.005 | |
| 0015918 | [ABCG4, APOB, NR1H3, OSBPL6, PNLIP] | Sterol transport | 0.009 | |
| 0030850 | [NOTCH1, SFTPA1, SFTPA2, WNT5A] | Prostate gland development | 0.012 | |
| 0048332 | [AXIN1, GNPDA1, WNT5A] | Mesoderm morphogenesis | 0.014 | |
| 0019915 | [APOB, DGAT2, FITM2, NR1H3] | Lipid storage | 0.026 | |
| 0001707 | [AXIN1, GNPDA1, WNT5A] | Mesoderm formation | 0.027 | |
| 0006536 | [ATAT1, GGT1, GLUD2] | Glutamate metabolic process | 0.028 | |
| 0006641 | [APOB, DGAT2, FITM2, INSIG1, NR1H3] | Triglyceride metabolic process | 0.028 | |
| 0042116 | [IL13, NR1H3, WNT5A] | Macrophage activation | 0.028 | |
| 0090207 | [DGAT2, FITM2, NR1H3] | Regulation of triglyceride metabolic process | 0.029 | |
| 0008206 | [ACAA1, CYP27A1, OSBPL6] | Bile acid metabolic process | 0.030 | |
| 0002637 | [EXOSC3, GNPDA1, IL13] | Regulation of immunoglobulin production | 0.033 | |
| 0070527 | [FERMT3, MYH9, PRKCQ] | Platelet aggregation | 0.033 | |
| 0002067 | [IL13, NOTCH1, WNT5A] | Glandular epithelial cell differentiation | 0.033 | |
| 0019217 | [DGAT2, INSIG1, NR1H3, PDHB] | Regulation of fatty acid metabolic process | 0.034 | |
| 0097006 | [APOB, DGAT2, PLAGL2] | Regulation of plasma lipoprotein particle levels | 0.035 | |
| 0055090 | [DGAT2, FITM2, NR1H3] | Acylglycerol homeostasis | 0.035 | |
| 0070328 | [DGAT2, FITM2, NR1H3] | Triglyceride homeostasis | 0.035 | |
| 0030301 | [ABCG4, APOB, NR1H3, PNLIP] | Cholesterol transport | 0.037 | |
| 0050830 | [DROSHA, HIST1H2BK, PGLYRP1, PGLYRP3] | Defence response to Gram-positive bacterium | 0.037 | |
| 0033344 | [ABCG4, APOB, NR1H3] | Cholesterol efflux | 0.038 | |
| 0002702 | [EXOSC3, GNPDA1, IL13, WNT5A] | Positive regulation of production of molecular mediator of immune response | 0.038 | |
| 0030514 | [CHRDL1, NOTCH1, WNT5A] | Negative regulation of BMP signaling pathway | 0.038 | |
| 0010883 | [APOB, FITM2, NR1H3] | Regulation of lipid storage | 0.039 | |
| 0019432 | [DGAT2, FITM2, NR1H3] | Triglyceride biosynthetic process | 0.039 | |
| 0043030 | [IL13, NR1H3, WNT5A] | Regulation of macrophage activation | 0.039 | |
| 0045599 | [AXIN1, INSIG1, WNT5A] | Negative regulation of fat cell differentiation | 0.040 | |
| 0002639 | [EXOSC3, GNPDA1, IL13] | Positive regulation of immunoglobulin production | 0.040 | |
| 0046460 | [DGAT2, FITM2, NR1H3] | Neutral lipid biosynthetic process | 0.040 | |
| 0046463 | [DGAT2, FITM2, NR1H3] | Acylglycerol biosynthetic process | 0.040 | |
| 0043153 | [BHLHE40, PPP1CB, PPP1CC] | Entrainment of circadian clock by photoperiod | 0.004 | |
| 1903844 | [ING3, ONECUT2, SKI, STRAP, XBP1] | Regulation of cellular response to transforming growth factor beta stimulus | 0.008 | |
| 0017015 | [ING3, ONECUT2, SKI, STRAP, XBP1] | Regulation of transforming growth factor beta receptor signaling pathway | 0.008 | |
| 0009648 | [BHLHE40, PPP1CB, PPP1CC] | Photoperiodism | 0.008 | |
| 0009649 | [BHLHE40, PPP1CB, PPP1CC] | Entrainment of circadian clock | 0.008 | |
| 1903845 | [ONECUT2, SKI, STRAP, XBP1] | Negative regulation of cellular response to transforming growth factor beta stimulus | 0.012 | |
| 0030512 | [ONECUT2, SKI, STRAP, XBP1] | Negative regulation of transforming growth factor beta receptor signaling pathway | 0.012 | |
| 0010923 | [FKBP1B, PPP1R1B, TMEM225] | Negative regulation of phosphatase activity | 0.014 | |
| 0032755 | [IL1RL2, TLR6, XBP1] | Positive regulation of interleukin-6 production | 0.025 | |
| 0045582 | [IL1RL2, ITPKB, XBP1] | Positive regulation of T cell differentiation | 0.025 | |
| 0035304 | [FKBP1B, PPP1R1B, SMPD1] | Regulation of protein dephosphorylation | 0.035 | |
| 0071230 | [CASTOR1, PDGFC, XBP1] | Cellular response to amino acid stimulus | 0.035 | |
| 1903036 | [FKBP1B, SCARF1, XBP1] | Positive regulation of response to wounding | 0.040 | |
| 0010257 | [NDUFAF6, NDUFC1, NDUFS7] | NADH dehydrogenase complex assembly | 0.042 | |
| 0032981 | [NDUFAF6, NDUFC1, NDUFS7] | Mitochondrial respiratory chain complex I assembly | 0.042 | |
| 0097031 | [NDUFAF6, NDUFC1, NDUFS7] | Mitochondrial respiratory chain complex I biogenesis | 0.042 | |
| 0032922 | [BHLHE40, PPP1CB, PPP1CC] | Circadian regulation of gene expression | 0.047 |
Indicated are gene ontology IDs (GO-ID), gene ontology terms (GO-term), associated genes found and corrected P values as determined by ClueGO (https://apps.cytoscape.org/apps/cluego). *Term P value corrected with Bonferroni step down.
Figure 3Principal component analysis considering (a) the 19,240 mRNAs expressed at least in triplicate in the oocytes (OOs), (b) the 21,277 mRNAs expressed at least in triplicate in the Follicular cells (FCs). Samples 1–5 from non-breeding season (NBS), samples 6–10 from breeding season (BS).
Differentially expressed gene DEGs (false discovery rate (FDR) < 0.05) calculated between the two seasons (non breeding season NBS, breeding season) for oocytes (OOs) and follicular cells (FCs).
| OOs (NBS vs BS) | FCs (NBS vs BS) | ||||||
|---|---|---|---|---|---|---|---|
| GENE ID | Human and cattle ortholog | logFC | FDR | GENE ID | Human and cattle ortholog | logFC | FDR |
| APOE | APOE | − 4.7 | 8.6E−07 | LOC102409538 | RNF213 | − 4.7 | 5.6E−04 |
| LOC102397479 | LOC102397479 | − 5.2 | 1.3E−05 | COL26A1 | COL26A1 | 2.1 | 2.3E−02 |
| PLXNA4 | PLXNA4 | − 2.3 | 2.6E−05 | ||||
| IGF2 | IGF2 | − 4.7 | 5.2E−04 | ||||
| FOLR2 | FOLR2 | − 7.5 | 8.0E−04 | ||||
| CD14 | CD14 | − 8.7 | 8.7E−04 | ||||
| SPP1 | SPP1 | − 3.2 | 2.5E−03 | ||||
| LOC102409999 | CD163 | − 4.7 | 2.8E−03 | ||||
| CTSS | CTSS | − 5.3 | 2.8E−03 | ||||
| LOC102413141 | GTF2IRD2 | − 0.7 | 3.9E−03 | ||||
| LOC102392787 | IL1B | − 5.0 | 6.1E−03 | ||||
| LOC112581169 | LOC112581169 | − 0.9 | 7.6E−03 | ||||
| CCL1 | CCL1 | − 1.2 | 9.7E−03 | ||||
| CTSK | CTSK | − 3.8 | 9.7E−03 | ||||
| LOC102415727 | regakine 1 | − 5.3 | 1.1E−02 | ||||
| MSR1 | MSR1 | − 3.7 | 1.2E−02 | ||||
| RUNX2 | RUNX2 | − 1.3 | 1.9E−02 | ||||
| LOC102404545 | LOC102404545 | 2.3 | 2.1E−02 | ||||
| LOC102400151 | CYP11A1 | − 2.6 | 2.3E−02 | ||||
| LOC102409533 | HSPA1A | − 0.8 | 3.6E−02 | ||||
| NMB | NMB | − 1.9 | 4.7E−02 | ||||
| LOC112582161 | LOC112582161 | 0.9 | 4.8E−02 | ||||
GO terms identified for the differentially expressed gene (DEGs) between the two seasons for oocytes (OOs).
| GOID | Associated genes found | GO term | |
|---|---|---|---|
| GO:19915 | [APOE, IL1B, MSR1] | Lipid storage | 7.17E−05 |
| GO:32370 | [APOE, IL1B, SPP1] | Positive regulation of lipid transport | 8.94E−05 |
| GO:32677 | [CD14, HSPA1A, IL1B] | Regulation of interleukin-8 production | 4.09E−05 |
| GO:32757 | [CD14, HSPA1A, IL1B] | Positive regulation of interleukin-8 production | 6.29E−05 |
| GO:1905954 | [APOE, IL1B, MSR1, SPP1] | Positive regulation of lipid localization | 5.76E−06 |
Indicated are gene ontology IDs (GO-ID), gene ontology terms (GO-term), associated genes found and corrected P values as determined by ClueGO (https://apps.cytoscape.org/apps/cluego).
* Term P value corrected with Bonferroni step down.
Figure 4Venn diagram (https://bioinfogp.cnb.csic.es/tools/venny/ version 2.1) representing the intersection (n = 6) between differentially expressed genes (DEGs, n = 22) and target genes of the differentially expressed miRNAs (DE-miRNAs, n = 6,712) in oocytes collected in the NBS and BS. Shared genes with their relative target miRNAs are reported. ↑indicates overexpression in breeding season (both for genes and miRNAs).